Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study.

ABSTRACT: Improved surgical techniques and greater efficacy of new anti-rejection drugs have significantly improved the survival of patients undergoing orthotopic liver transplantation (OLT). This has led to an increased incidence of metabolic disorders as well as cardiovascular and cerebrovascular diseases as causes of morbidity and mortality in OLT patients. In the last decade, several studies have examined which predisposing factors lead to increased cardiovascular risk (i.e., age, ethnicity, diabetes, NASH, atrial fibrillation, and some echocardiographic parameters) as well as which factors after OLT (i.e., weight gain, metabolic syndrome, immunosuppressive therapy, and renal failure) are linked to increased cardiovascular mortality. However, currently, there are no available data

SUBMITTER: Pisano G 

PROVIDER: S-EPMC5083792 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature